← Alle ziektes
Infectieziekten
Resistente tuberculose
Wil je bericht krijgen als er nieuw onderzoek is over Resistente tuberculose? Dat kan met een account. Maak een gratis account of log in.
Automatisch bijgehouden uit PubMed en ClinicalTrials.gov, nieuwste bovenaan. Er verdwijnt hier nooit iets: wat je in je favorieten bewaart, blijft vindbaar. · RSS-feed van deze ziekte · alleen het zwaarste bewijs
In gewone taal lezen waar elke studie over gaat? Met Premium staat boven elke publicatie één zin die uitlegt wat er onderzocht is — en krijg je bericht zodra er nieuw onderzoek is over Resistente tuberculose. Bekijk wat Premium kost.
Publicaties (1322)
- Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus. (2026/07/23) ♡
- National genomic survey of drug-resistance and multi-jurisdictional clusters of Mycobacterium tuberculosis in Australia 2015-2023. (2026/07/23) ♡
- Rifabutin Cross-resistance and Associated rpoB Mutations in Rifampicin-resistant Mycobacterium tuberculosis Complex Isolates. (2026/07/22) ♡
- Isolated Forearm Abscess with Bilateral Psoas Abscesses: An Unusual Presentation of Extrapulmonary Preextensively Drug-resistant Tuberculosis without Pulmonary Involvement. (2026/07/22) ♡
- Beschrijving van enkele patiënteniHet verhaal van één of een paar patiënten. Leerzaam, maar je kunt er niet uit afleiden of iets in het algemeen werkt. Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of Mycobacterium avium Complex-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing. (2026/07/22) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. Heteroresistance in Mycobacterium tuberculosis: from molecular mechanisms and advanced detection to clinical implications. (2026/07/22) ♡
- Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in Mycobacterium tuberculosis clinical isolates. (2026/07/22) ♡
- Tuberculosis notifications in Australia, 2019-2020. (2026/07/21) ♡
- Genomic insights into low-level rifampicin resistance mediated by borderline rpoB mutations in Mycobacterium tuberculosis: prevalence and phylogeny in Northeast China. (2026/07/21) ♡
- Towards culture-free sequencing of Mycobacterium tuberculosis: evaluating new targeted and whole-genome approaches for genotyping and drug resistance profiling. (2026/07/21) ♡
- The First Documented Case of Congenital Drug-Resistant Tuberculosis in Indonesia: A Case Report. (2026/07/20) ♡
- Characteristics, Treatment Strategies, and Long-term Health Outcomes of People With Bedaquiline-resistant Tuberculosis in Karakalpakstan, Uzbekistan-A Retrospective Cohort Study. (2026/07/20) ♡
- Drug resistance in tuberculous meningitis: A laboratory-based observational study from Northern India's tertiary care referral centre. (2026/07/20) ♡
- Multidrug resistant tuberculosis (MDR-TB) in Eritrea: a retrospective cohort analysis of mortality and associated factors (2013 - 2023). (2026/07/20) ♡
- MTK_MCPA: A novel magnesium-competitive inhibitor of Mycobacterium tuberculosis thymidylate kinase. (2026/07/17) ♡
- National and subnational burden of HIV-negative MDR-TB in China, 1990-2023: Spatio-temporal heterogeneity, long-term trends, and projections. (2026/07/17) ♡
- From linezolid to contezolid: a strategy for safe continuation of therapy in complex tuberculosis. (2026/07/17) ♡
- Systematisch overzichtiAl het onderzoek over één vraag is volgens vaste regels opgezocht en naast elkaar gelegd, zodat er geen studies zijn overgeslagen die slecht uitkwamen. Associated characteristics of multidrug-resistant tuberculosis (MDR-TB) cases in Sub-Saharan Africa: a systematic review and meta-analysis. (2026/07/16) ♡
- Community-based, peer-led psychosocial support to address stigma and reduce depression among adults with tuberculosis in Indonesia: A prospective interventional cohort study. (2026/07/16) ♡
- Hepatic and splenic tuberculosis following infliximab therapy for refractory ulcerative colitis: a case report and literature review. (2026/07/16) ♡
- Performance of next-generation sequencing technologies for detecting drug-resistant tuberculosis in people with pulmonary tuberculosis. (2026/07/15) ♡
- Longer vs. shorter all-oral bedaquiline-based regimens for drug-resistant tuberculosis: real-world evidence from a high-burden setting. (2026/07/15) ♡
- Assessment of differentially culturable tubercle bacteria assays for the detection of tuberculosis infection in asymptomatic household contacts and the implications for intra-household transmission: a longitudinal cohort study. (2026/07/15) ♡
- "I Would Have to Hold Him and Pin Him Down": Caregiver Experiences of Administering Drug-Resistant Tuberculosis Treatment to Children in KwaZulu-Natal, South Africa. (2026/07/15) ♡
- Clinical and Microbiological Characteristics Associated with Treatment Outcomes Among Rifampicin-Resistant Tuberculosis Patients in Limpopo Province. (2026/07/14) ♡
- Commentaar of redactioneeliEen mening of toelichting van een deskundige, geen nieuw onderzoek. High-dose linezolid during BPaL implementation for pre-extensively drug-resistant TB or failure/intolerance of rifampicin-resistant TB regimens. (2026/07/13) ♡
- Quantifying emergent drug-resistant TB using laboratory data and record-linkage methods. (2026/07/13) ♡
- Nurse case management to improve multidrug-resistant TB: a cluster-randomised trial. (2026/07/13) ♡
- Household costs and health-related quality of life of childhood multidrug-resistant TB in Western Cape, South Africa. (2026/07/13) ♡
- Genomic profile and infection dynamics of Kashi_RDG1 (KRDG1), a novel cluster K1 mycobacteriophage infecting mycobacterial hosts. (2026/07/13) ♡
- A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China. (2026/07/10) ♡
- Fluoroquinolone resistance and mutation profiles in Mycobacterium tuberculosis through whole genome sequencing in Fujian province, China. (2026/07/09) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. Immunotherapy for tuberculosis: emerging modalities, cross-disciplinary innovations, and roadmaps for drug-resistant disease. (2026/07/09) ♡
- Population-level and longitudinal MIC distributions for antimicrobials against drug-resistant Mycobacterium tuberculosis in Wuxi, a low-epidemic city in China, from 2019 to 2023. (2026/07/08) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. Current Landscape of Molecular Diagnostic Tests and Emerging Tools for Tuberculosis and Drug Resistance. (2026/07/07) ♡
- Evaluation of the GenoScreen Deeplex Myc-TB workflow for drug-resistant tuberculosis testing in South Africa. (2026/07/07) ♡
- Body Mass Index Trajectories Among Patients with Drug-Susceptible and Drug-Resistant Tuberculosis in Northwest Ethiopia. (2026/07/07) ♡
- Fucoidan-Functionalized Nanoparticles for Antimycobacterial Therapy: A Promising Approach against Drug-Resistant Mycobacterium tuberculosis Strains. (2026/07/03) ♡
- Divergent Trajectories of Pediatric All-Form Tuberculosis and Multidrug-Resistant Tuberculosis from 1990 to 2021. (2026/07/03) ♡
- Temporal dynamics and regional disparities in HIV/AIDS and extensively drug-resistant tuberculosis mortality in South Asia: A systemic analysis of global burden of disease data (1993-2021). (2026/07/01) ♡
- Utility of second sample testing in Indian children suffering from tuberculosis with rifampicin indeterminate results on Xpert MTB/Rif and Xpert Ultra assays. (2026/07/01) ♡
- Klinisch onderzoekiOnderzoek bij patiënten, zonder dat er geloot is tussen groepen. Bruikbaar, maar minder zeker dan een gerandomiseerd onderzoek. Limited success and high attrition in the 9-month all-oral regimen for MDR-TB: Evidence from a tertiary care setting in Indonesia. (2026/07/01) ♡
- Beschrijving van enkele patiënteniHet verhaal van één of een paar patiënten. Leerzaam, maar je kunt er niet uit afleiden of iets in het algemeen werkt. Imipenem-cilastatin and Linezolid induced black hairy tongue and teeth used in an Extremely drug resistant tuberculosis (XXDR)- case report and its clinical implications. (2026/07/01) ♡
- Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis. (2026/07/01) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives. (2026/07/01) ♡
- A hospital-based genomic analysis reveals predominance of ST215 Mycobacterium tuberculosis with low drug resistance. (2026/07/01) ♡
- Clinical characteristics, drug resistance profiles, and inflammatory cytokine signatures in newly treated versus retreated MDR/RR-TB patients: associations with treatment outcomes. (2026/07/01) ♡
- Kinetical Analysis of Mutant PZase Enzyme To Uncover The Pyrazinamide Resistance In Mycobacterium tuberculosis Clinical Isolates. (2026/07/01) ♡
- Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. (2026/07/01) ♡
- Laboratorium- of dieronderzoekiNog geen onderzoek bij mensen. Veelbelovend in een reageerbuis of bij muizen betekent helaas nog niets voor patiënten. In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis. (2026/06/29) ♡
codex.care geeft geen medisch advies. Bespreek klachten, medicatie en behandelkeuzes altijd met je eigen behandelaar.